GEORGE TOWN GRAND CAYMAN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $67.3 million in its fourth quarter.
The George Town Grand Cayman, Cayman Islands-based company said it had a loss of $1.36 per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.07 per share.
The biopharmaceutical company posted revenue of $5.7 million in the period.
For the year, the company reported that its loss widened to $190.7 million, or $4.26 per share. Revenue was reported as $48.6 million.
Theravance Bio shares have climbed slightly since the beginning of the year. In the final minutes of trading on Monday, shares hit $31.99, an increase of 98 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH
Keywords: Theravance Biopharma, Earnings Report